𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART)

✍ Scribed by Laurent Michel; Roch Giorgi; Virginie Villes; Isabelle Poizot-Martin; Pierre Dellamonica; Bruno Spire; Camelia Protopopescu; M. Patrizia Carrieri

Book ID
116412161
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
192 KB
Volume
99
Category
Article
ISSN
0376-8716

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatitis C virus quasispecies in HIV-in
Hepatitis C virus quasispecies in HIV-infected women: Role of injecting drug use and highly active antiretroviral therapy (HAART)
✍ Tomasz Laskus; Jeffrey Wilkinson; Roksana Karim; Wendy Mack; Marek Radkowski; Ma πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 339 KB πŸ‘ 2 views

Despite the high frequency of HCV and HIV coinfection, little is known about HCV quasispecies in HIV-positive patients. The current analysis included 236 HIV+/anti-HCV+ women enrolled in the Women's Interagency HIV Study (WIHS). Hypervariable region 1 of the second envelope gene was analyzed by sing

Sonographically measured perirenal fat t
Sonographically measured perirenal fat thickness: An early predictor of atherosclerosis in HIV-1-infected patients receiving highly active antiretroviral therapy?
✍ Pierfrancesco Grima; Marcello Guido; Antonella Zizza; Roberto Chiavaroli πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 194 KB

## Abstract ## Purpose. The aim of our study was to evaluate whether perirenal fat thickness (PRFT), a parameter of central obesity, is related to carotid intima‐media thickness (IMT), an index of atherosclerosis in human immunodeficiency virus (HIV)‐1‐infected patients. ## Methods. We enrolled

Soluble urokinase plasminogen activator
Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy
✍ Ove Andersen; Jesper Eugen-Olsen; Kristian Kofoed; Johan Iversen; Steen B. Hauga πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 224 KB

## Abstract Circulating soluble urokinase plasminogen activator receptor (suPAR) reflects the immune and pro‐inflammatory status of the HIV‐infected patient. Highly active antiretroviral therapy (HAART) suppresses suPAR. Independent of the immune response to HAART, suPAR remains elevated in some HI